Skip to main content
Top
Published in: AIDS and Behavior 9/2021

01-09-2021 | Human Immunodeficiency Virus | Original Paper

The Impact of COVID-19 on HIV Self-Management, Affective Symptoms, and Stress in People Living with HIV in the United States

Authors: Rachel K. Wion, Wendy R. Miller

Published in: AIDS and Behavior | Issue 9/2021

Login to get access

Abstract

COVID-19 has the potential to detrimentally impact HIV self-management in people living with HIV (PLHIV). Effective HIV-self management is critically important in managing symptoms as well as viral suppression. We examined the impact of the COVID-19 pandemic on HIV self-management, social support, social isolation, depressive symptoms, anxiety, and stress in PLHIV. 85 PLHIV were recruited from social media sites and completed an online survey. Data were collected between April 23 and 30, 2020. Participants reported increases in social isolation, depressive symptoms, anxiety, and stress and decreases in social support and overall HIV self-management from pre- to during the pandemic. Additionally, the Social Support domain and Chronic Nature of HIV domain of the HIV Self-Management Scale were also decreased from pre- to during the pandemic. The ability for PLHIV to maintain HIV self-management during this time is essential and HIV care providers should have plans in place to provide support.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization. Timeline of WHO’s response to COVID-19. Geneva: WHO; 2020.CrossRef World Health Organization. Timeline of WHO’s response to COVID-19. Geneva: WHO; 2020.CrossRef
2.
go back to reference Gostin LO, Wiley LF. Governmental public health powers during the COVID-19 pandemic: stay-at-home orders, business closures, and travel restrictions. JAMA. 2020;323(21):2137–8.CrossRef Gostin LO, Wiley LF. Governmental public health powers during the COVID-19 pandemic: stay-at-home orders, business closures, and travel restrictions. JAMA. 2020;323(21):2137–8.CrossRef
3.
go back to reference Banerjee M, Chakraborty S, Pal R. Diabetes self-management amid COVID-19 pandemic. Diabetes Metab Syndr. 2020;14(4):351–4.CrossRef Banerjee M, Chakraborty S, Pal R. Diabetes self-management amid COVID-19 pandemic. Diabetes Metab Syndr. 2020;14(4):351–4.CrossRef
4.
go back to reference Druss BG. Addressing the COVID-19 pandemic in populations with serious mental illness. JAMA Psychiat. 2020;77(9):891–2.CrossRef Druss BG. Addressing the COVID-19 pandemic in populations with serious mental illness. JAMA Psychiat. 2020;77(9):891–2.CrossRef
5.
go back to reference Helmich RC, Bloem BR. The impact of the COVID-19 pandemic on Parkinson’s disease: hidden sorrows and emerging opportunities. J Parkinsons Dis. 2020;10(2):351–4.CrossRef Helmich RC, Bloem BR. The impact of the COVID-19 pandemic on Parkinson’s disease: hidden sorrows and emerging opportunities. J Parkinsons Dis. 2020;10(2):351–4.CrossRef
6.
go back to reference Kalichman SC, Eaton LA, Berman M, et al. Intersecting pandemics: impact of SARS-CoV-2 (COVID-19) protective behaviors on people living with HIV, Atlanta, Georgia. J Acquir Immune Defic Syndr. 2020;85(1):66–72.CrossRef Kalichman SC, Eaton LA, Berman M, et al. Intersecting pandemics: impact of SARS-CoV-2 (COVID-19) protective behaviors on people living with HIV, Atlanta, Georgia. J Acquir Immune Defic Syndr. 2020;85(1):66–72.CrossRef
7.
go back to reference Centers for Disease Control and Prevention. People who are at increased risk for severe illness. Atlanta: Centers for Disease Control and Prevention; 2020. Centers for Disease Control and Prevention. People who are at increased risk for severe illness. Atlanta: Centers for Disease Control and Prevention; 2020.
8.
go back to reference Vizcarra P, Pérez-Elías MJ, Quereda C, et al. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV. 2020;7(8):e554–64.CrossRef Vizcarra P, Pérez-Elías MJ, Quereda C, et al. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV. 2020;7(8):e554–64.CrossRef
9.
go back to reference Gervasoni C, Meraviglia P, Riva A, et al. Clinical features and outcomes of HIV patients with coronavirus disease 2019. Clin Infect Dis. 2020;71(16):2276–8.CrossRef Gervasoni C, Meraviglia P, Riva A, et al. Clinical features and outcomes of HIV patients with coronavirus disease 2019. Clin Infect Dis. 2020;71(16):2276–8.CrossRef
10.
go back to reference Del Amo J, Polo R, Moreno S, et al. Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy: a cohort study. Ann Intern Med. 2020;173(7):536–41.CrossRef Del Amo J, Polo R, Moreno S, et al. Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy: a cohort study. Ann Intern Med. 2020;173(7):536–41.CrossRef
12.
go back to reference Iribarren S, Siegel K, Hirshfield S, et al. Self-management strategies for coping with adverse symptoms in persons living with HIV with HIV associated non-AIDS conditions. AIDS Behav. 2018;22(1):297–307.CrossRef Iribarren S, Siegel K, Hirshfield S, et al. Self-management strategies for coping with adverse symptoms in persons living with HIV with HIV associated non-AIDS conditions. AIDS Behav. 2018;22(1):297–307.CrossRef
13.
go back to reference Schnall R, Wantland D, Velez O, Cato K, Jia H. Feasibility testing of a web-based symptom self-management system for persons living with HIV. J Assoc Nurses AIDS Care. 2014;25(4):364–71.CrossRef Schnall R, Wantland D, Velez O, Cato K, Jia H. Feasibility testing of a web-based symptom self-management system for persons living with HIV. J Assoc Nurses AIDS Care. 2014;25(4):364–71.CrossRef
14.
go back to reference Webel AR, Asher A, Cuca Y, et al. Measuring HIV self-management in women living with HIV/AIDS: a psychometric evaluation study of the HIV Self-management Scale. J Acquir Immune Defic Syndr. 2012;60(3):e72-81.CrossRef Webel AR, Asher A, Cuca Y, et al. Measuring HIV self-management in women living with HIV/AIDS: a psychometric evaluation study of the HIV Self-management Scale. J Acquir Immune Defic Syndr. 2012;60(3):e72-81.CrossRef
15.
go back to reference Algarin AB, Varas-Rodríguez E, Valdivia C, et al. Symptoms, stress, and HIV-related care among older people living with HIV during the COVID-19 pandemic, Miami, Florida. AIDS Behav. 2020;24(8):2236–8.CrossRef Algarin AB, Varas-Rodríguez E, Valdivia C, et al. Symptoms, stress, and HIV-related care among older people living with HIV during the COVID-19 pandemic, Miami, Florida. AIDS Behav. 2020;24(8):2236–8.CrossRef
16.
go back to reference Santos G-M, Ackerman B, Rao A, et al. Economic, mental health, HIV prevention and HIV treatment impacts of COVID-19 and the COVID-19 response on a global sample of cisgender gay men and other men who have sex with men. AIDS Behav. 2020;25(2):311–21.CrossRef Santos G-M, Ackerman B, Rao A, et al. Economic, mental health, HIV prevention and HIV treatment impacts of COVID-19 and the COVID-19 response on a global sample of cisgender gay men and other men who have sex with men. AIDS Behav. 2020;25(2):311–21.CrossRef
17.
go back to reference Chenneville T, Gabbidon K, Hanson P, Holyfield C. The impact of COVID-19 on HIV treatment and research: a call to action. Int J Environ Res Public Health. 2020;17(12):4548.CrossRef Chenneville T, Gabbidon K, Hanson P, Holyfield C. The impact of COVID-19 on HIV treatment and research: a call to action. Int J Environ Res Public Health. 2020;17(12):4548.CrossRef
18.
go back to reference Webel AR, Sattar A, Schreiner N, Kinley B, Moore SM, Salata RA. The impact of mental wellness on HIV self-management. J Assoc Nurses AIDS Care. 2016;27(4):468–75.CrossRef Webel AR, Sattar A, Schreiner N, Kinley B, Moore SM, Salata RA. The impact of mental wellness on HIV self-management. J Assoc Nurses AIDS Care. 2016;27(4):468–75.CrossRef
19.
go back to reference Pilkonis PA, Choi SW, Reise SP, et al. Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS®): depression, anxiety, and anger. Assessment. 2011;18(3):263–83.CrossRef Pilkonis PA, Choi SW, Reise SP, et al. Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS®): depression, anxiety, and anger. Assessment. 2011;18(3):263–83.CrossRef
20.
go back to reference Salsman JM, Butt Z, Pilkonis PA, et al. Emotion assessment using the NIH Toolbox. Neurology. 2013;80(11 Suppl 3):S76-86.CrossRef Salsman JM, Butt Z, Pilkonis PA, et al. Emotion assessment using the NIH Toolbox. Neurology. 2013;80(11 Suppl 3):S76-86.CrossRef
21.
go back to reference United States Census Bureau. 2010 census regions and divisions of the United States. Suitland: United States Census Bureau; 2010. United States Census Bureau. 2010 census regions and divisions of the United States. Suitland: United States Census Bureau; 2010.
22.
go back to reference Heissel A, Zech P, Rapp MA, et al. Effects of exercise on depression and anxiety in persons living with HIV: a meta-analysis. J Psychosom Res. 2019;126:109823–920.CrossRef Heissel A, Zech P, Rapp MA, et al. Effects of exercise on depression and anxiety in persons living with HIV: a meta-analysis. J Psychosom Res. 2019;126:109823–920.CrossRef
23.
go back to reference Oliveira VHF, Rosa FT, Santos JC, et al. Effects of a combined exercise training program on health indicators and quality of life of people living with HIV: a randomized clinical trial. AIDS Behav. 2020;24(5):1531–41.CrossRef Oliveira VHF, Rosa FT, Santos JC, et al. Effects of a combined exercise training program on health indicators and quality of life of people living with HIV: a randomized clinical trial. AIDS Behav. 2020;24(5):1531–41.CrossRef
24.
go back to reference Bhochhibhoya A, Qiao S, Mao Y, et al. Physical activity, depression, and antiretroviral therapy adherence among people living with HIV: a mediation analysis. J Assoc Nurses AIDS Care. 2019;30(5):556–62.CrossRef Bhochhibhoya A, Qiao S, Mao Y, et al. Physical activity, depression, and antiretroviral therapy adherence among people living with HIV: a mediation analysis. J Assoc Nurses AIDS Care. 2019;30(5):556–62.CrossRef
25.
go back to reference Downing MJ, Millar BM, Hirshfield S. Changes in sleep quality and associated health outcomes among gay and bisexual men living with HIV. Behav Sleep Med. 2020;18(3):406–19.CrossRef Downing MJ, Millar BM, Hirshfield S. Changes in sleep quality and associated health outcomes among gay and bisexual men living with HIV. Behav Sleep Med. 2020;18(3):406–19.CrossRef
26.
go back to reference Andini S, Yona S, Waluyo A. Self-efficacy, depression, and adherence to antiretroviral therapy (ART) among Indonesian women with HIV. Enferm Clin. 2019;29(Suppl 2):687–90.CrossRef Andini S, Yona S, Waluyo A. Self-efficacy, depression, and adherence to antiretroviral therapy (ART) among Indonesian women with HIV. Enferm Clin. 2019;29(Suppl 2):687–90.CrossRef
27.
go back to reference Mills JC, Pence BW, Edmonds A, et al. The impact of cumulative depression along the HIV care continuum in women living with HIV during the era of universal antiretroviral treatment. J Acquir Immune Defic Syndr. 2019;82(3):225–33.CrossRef Mills JC, Pence BW, Edmonds A, et al. The impact of cumulative depression along the HIV care continuum in women living with HIV during the era of universal antiretroviral treatment. J Acquir Immune Defic Syndr. 2019;82(3):225–33.CrossRef
28.
go back to reference Wykowski J, Kemp CG, Velloza J, Rao D, Drain PK. Associations between anxiety and adherence to antiretroviral medications in low- and middle-income countries: a systematic review and meta-analysis. AIDS Behav. 2019;23(8):2059–71.CrossRef Wykowski J, Kemp CG, Velloza J, Rao D, Drain PK. Associations between anxiety and adherence to antiretroviral medications in low- and middle-income countries: a systematic review and meta-analysis. AIDS Behav. 2019;23(8):2059–71.CrossRef
29.
go back to reference Benoit AC, Burchell AN, O’Brien KK, et al. Examining the association between stress and antiretroviral therapy adherence among women living with HIV in Toronto, Ontario. HIV Res Clin Pract. 2020;21(2–3):45–55.CrossRef Benoit AC, Burchell AN, O’Brien KK, et al. Examining the association between stress and antiretroviral therapy adherence among women living with HIV in Toronto, Ontario. HIV Res Clin Pract. 2020;21(2–3):45–55.CrossRef
30.
go back to reference Garrido-Hernansaiz H, Alonso-Tapia J. Social support in newly diagnosed people living with HIV: expectations and satisfaction along time, predictors, and mental health correlates. J Assoc Nurses AIDS Care. 2017;28(6):849–61.CrossRef Garrido-Hernansaiz H, Alonso-Tapia J. Social support in newly diagnosed people living with HIV: expectations and satisfaction along time, predictors, and mental health correlates. J Assoc Nurses AIDS Care. 2017;28(6):849–61.CrossRef
31.
go back to reference Matsumoto S, Yamaoka K, Takahashi K, et al. Social support as a key protective factor against depression in HIV-infected patients: report from large HIV clinics in Hanoi, Vietnam. Sci Rep. 2017;7(1):15489.CrossRef Matsumoto S, Yamaoka K, Takahashi K, et al. Social support as a key protective factor against depression in HIV-infected patients: report from large HIV clinics in Hanoi, Vietnam. Sci Rep. 2017;7(1):15489.CrossRef
32.
go back to reference Chandran A, Benning L, Musci RJ, et al. The longitudinal association between social support on HIV medication adherence and healthcare utilization in the Women’s Interagency HIV Study. AIDS Behav. 2019;23(8):2014–24.CrossRef Chandran A, Benning L, Musci RJ, et al. The longitudinal association between social support on HIV medication adherence and healthcare utilization in the Women’s Interagency HIV Study. AIDS Behav. 2019;23(8):2014–24.CrossRef
33.
go back to reference Kelly JD, Hartman C, Graham J, Kallen MA, Giordano TP. Social support as a predictor of early diagnosis, linkage, retention, and adherence to HIV care: results from the steps study. J Assoc Nurses AIDS Care. 2014;25(5):405–13.CrossRef Kelly JD, Hartman C, Graham J, Kallen MA, Giordano TP. Social support as a predictor of early diagnosis, linkage, retention, and adherence to HIV care: results from the steps study. J Assoc Nurses AIDS Care. 2014;25(5):405–13.CrossRef
34.
go back to reference Camargo CC, Cavassan NRV, Tasca KI, Meneguin S, Miot HA, Souza LR. Depression and coping are associated with failure of adherence to antiretroviral therapy among people living with HIV/AIDS. AIDS Res Hum Retroviruses. 2019;35(11–12):1181–8.CrossRef Camargo CC, Cavassan NRV, Tasca KI, Meneguin S, Miot HA, Souza LR. Depression and coping are associated with failure of adherence to antiretroviral therapy among people living with HIV/AIDS. AIDS Res Hum Retroviruses. 2019;35(11–12):1181–8.CrossRef
35.
go back to reference Vyavaharkar M, Moneyham L, Tavakoli A, et al. Social support, coping, and medication adherence among HIV-positive women with depression living in rural areas of the southeastern United States. AIDS Patient Care STDS. 2007;21(9):667–80.CrossRef Vyavaharkar M, Moneyham L, Tavakoli A, et al. Social support, coping, and medication adherence among HIV-positive women with depression living in rural areas of the southeastern United States. AIDS Patient Care STDS. 2007;21(9):667–80.CrossRef
Metadata
Title
The Impact of COVID-19 on HIV Self-Management, Affective Symptoms, and Stress in People Living with HIV in the United States
Authors
Rachel K. Wion
Wendy R. Miller
Publication date
01-09-2021
Publisher
Springer US
Published in
AIDS and Behavior / Issue 9/2021
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-021-03335-4

Other articles of this Issue 9/2021

AIDS and Behavior 9/2021 Go to the issue